APA (7th ed.) Citation

JD, M., FS, L., AM, R., EM, V., R, R., R, F., & F, S. (2018). Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease). Stem cell research & therapy, 9(1), 150. https://doi.org/10.1186/s13287-018-0901-6

Chicago Style (17th ed.) Citation

JD, Martin-Rufino, Lozano FS, Redondo AM, Villaron EM, Rueda R, Fernandez-Samos R, and Sanchez-Guijo F. "Sequential Intravenous Allogeneic Mesenchymal Stromal Cells as a Potential Treatment for Thromboangiitis Obliterans (Buerger's Disease)." Stem Cell Research & Therapy 9, no. 1 (2018): 150. https://doi.org/10.1186/s13287-018-0901-6.

MLA (9th ed.) Citation

JD, Martin-Rufino, et al. "Sequential Intravenous Allogeneic Mesenchymal Stromal Cells as a Potential Treatment for Thromboangiitis Obliterans (Buerger's Disease)." Stem Cell Research & Therapy, vol. 9, no. 1, 2018, p. 150, https://doi.org/10.1186/s13287-018-0901-6.